Q32 Bio (QTTB) Institutional Ownership $32.95 -2.68 (-7.52%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Q32 Bio (NASDAQ:QTTB)CurrentInstitutional OwnershipPercentage31.32%Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$102.07MNumber ofInstitutional Sellers(last 12 months)0 Get QTTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QTTB Institutional Buying and Selling by Quarter Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Q32 Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC131,768$5.88M0.0%+22.4%1.082% 11/15/2024Barclays PLC10,443$465K0.0%+105.2%0.086% 11/15/2024Jane Street Group LLC16,437$733K0.0%N/A0.135% 11/15/2024 State Street Corp110,164$4.92M0.0%+35.5%0.904% 11/15/2024 Point72 Asset Management L.P.76,685$3.42M0.0%N/A0.630% 11/14/2024 Eventide Asset Management LLC190,000$8.48M0.1%N/A1.560% Get the Latest News and Ratings for QTTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024 MetLife Investment Management LLC3,563$159K0.0%N/A0.029% 11/13/2024 BNP Paribas Financial Markets1,298$58K0.0%+199.1%0.011% 11/13/2024 FMR LLC426,302$19.02M0.0%+137.3%3.500% 10/23/2024 Values First Advisors Inc.741$33K0.0%N/A0.006% 8/13/2024 Ensign Peak Advisors Inc64,481$1.16M0.0%+150.6%0.540% 8/9/2024 Renaissance Technologies LLC14,764$265K0.0%N/A0.124% 8/9/2024 Harvard Management Co. Inc.162,965$2.93M0.2%N/A1.365% 8/1/2024 Rhumbline Advisers7,658$137K0.0%+11,681.5%0.064% 7/26/2024 Bank of New York Mellon Corp17,569$315K0.0%N/A0.147% 5/17/2024 Ikarian Capital LLC22,335$381K0.0%N/A0.685% 5/15/2024 ARCH Venture Management LLC320,482$5.46M6.5%N/A9.831% 5/15/2024 Affinity Asset Advisors LLC27,777$473K0.1%N/A0.852% 5/14/2024 Platinum Investment Management Ltd.109,964$1.87M0.1%N/A3.373% 5/10/2024 Acadian Asset Management LLC3,695$62K0.0%N/A0.113% 5/10/2024 Vanguard Group Inc.107,752$1.84M0.0%N/A3.305% 5/6/2024 Atlas Venture Life Science Advisors LLC2,092,106$35.65M3.3%N/A64.254% 5/3/2024 Carlyle Group Inc.1,102,741$18.07M1.1%N/A33.826% 4/23/2024 BML Capital Management LLC24,894$424K0.3%N/A0.764% 4/22/2024 Vivo Capital LLC370,068$6.31M0.5%N/A11.366% (Data available from 1/1/2016 forward) QTTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QTTB shares? During the previous two years, 25 institutional investors and hedge funds held shares of Q32 Bio. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($35.65M), FMR LLC ($19.02M), Carlyle Group Inc. ($18.07M), Eventide Asset Management LLC ($8.48M), Vivo Capital LLC ($6.31M), Geode Capital Management LLC ($5.88M), and ARCH Venture Management LLC ($5.46M).Learn more on QTTB's institutional investors. What percentage of Q32 Bio stock is owned by institutional investors? 31.32% of Q32 Bio stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings. Which institutional investors have been buying Q32 Bio stock? Of the 25 institutional investors that purchased Q32 Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Vivo Capital LLC ($370.07K), ARCH Venture Management LLC ($320.48K), FMR LLC ($246.66K), Eventide Asset Management LLC ($190K), and Harvard Management Co. Inc. ($162.97K). How much institutional buying is happening at Q32 Bio? Institutional investors have bought a total of 5,016,741 shares in the last 24 months. This purchase volume represents approximately $102.07M in transactions. Related Companies Harmony Biosciences Institutional Ownership Nurix Therapeutics Institutional Ownership Disc Medicine Institutional Ownership Galapagos Institutional Ownership Tarsus Pharmaceuticals Institutional Ownership Arvinas Institutional Ownership Immunocore Institutional Ownership Spyre Therapeutics Institutional Ownership Ocular Therapeutix Institutional Ownership Xencor Institutional Ownership This page (NASDAQ:QTTB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Q32 Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
